Literature DB >> 22642612

Prevalence and profile of sleep disturbances in Guillain-Barre Syndrome: a prospective questionnaire-based study during 10 days of hospitalization.

K Karkare1, S Sinha, A B Taly, S Rao.   

Abstract

INTRODUCTION: Sleep disturbances in Guillain-Barre Syndrome (GBS), though common, have not received focused attention.
OBJECTIVES: To study frequency and nature of sleep disturbances in patients with GBS, using validated questionnaires, and analyze the contributing factors.
MATERIALS AND METHODS: This prospective study included 60 patients fulfilling National Institute of Neurological and Communicative Diseases and Stroke (NINCDS) criteria for GBS (mean age: 32.7 ± 12.9 years; median: 30 years; M:F = 46:14), evaluated from 2008 to 2010. Data regarding sleep were collected on 10 consecutive days following admission using Richard Campbell Sleep score, St Mary's Hospital Sleep Questionnaire, and Pittsburgh Sleep Quality Index (PSQI) and correlated with various possible contributing factors like pain, paresthesia, anxiety, depression, autonomic dysfunctions, severity of disease, and therapeutic interventions among others. OBSERVATIONS: Qualitative and quantitative sleep disturbances were rather frequent and involved over 50% patients: abnormal PSQI - 13.3%, abnormal score on Richard scale - 51.6%, abnormal sleep onset latency - 35%, sleep fragmentation - 40%, and reduced sleep duration - 46.6%. The symptoms were severe during the first week of hospitalization and reduced thereafter. Sleep disturbances as scored on Richard scale significantly correlated with anxiety, pain, paresthesia, and severity of immobility (P < 0.05) but not with depression and use of analgesics or antineuritic drugs.
CONCLUSIONS: This study first of its kind suggests that sleep disturbance in GBS is frequent, multi-factorial, often disturbing, and varies during the course of illness. Routine enquiry into the sleep disturbances and timely intervention may reduce morbidity and improve their quality of life.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22642612     DOI: 10.1111/j.1600-0404.2012.01688.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  10 in total

Review 1.  Neuromuscular disorders and sleep in critically ill patients.

Authors:  Muna Irfan; Bernardo Selim; Alejandro A Rabinstein; Erik K St Louis
Journal:  Crit Care Clin       Date:  2015-07       Impact factor: 3.598

Review 2.  Sleep and neurological autoimmune diseases.

Authors:  Alex Iranzo
Journal:  Neuropsychopharmacology       Date:  2019-07-14       Impact factor: 7.853

Review 3.  Sleep Disturbances Associated with Neurological Autoimmunity.

Authors:  Michelle F Devine; Erik K St Louis
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

4.  Propofol and sufentanil may affect the patients' sleep quality independently of the surgical stress response: a prospective nonrandomized controlled trial in 1033 patients' undergone diagnostic upper gastrointestinal endoscopy.

Authors:  Ming Lei; Peng Zhang; Yunfei Liu; Fangfang Fu; Ling Ye; Tao Zhu
Journal:  BMC Anesthesiol       Date:  2017-03-31       Impact factor: 2.217

5.  Sleep and psychiatric abnormalities in Gullian Barré Syndrome.

Authors:  Wafik Said Bahnasy; Yasser Abo Elfotoh El-Heneedy; Ahmed Mohamed El-Shamy; Marwa Yassin Badr; Reham Ahmed Amer; Ibrahim Salah Eldeen Ibrahim
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2018-04-25

Review 6.  Psychiatric Sequelae of Guillain-Barré Syndrome: Towards a Multidisciplinary Team Approach.

Authors:  Christopher Hillyar; Anjan Nibber
Journal:  Cureus       Date:  2020-02-19

Review 7.  Role of Melatonin on Virus-Induced Neuropathogenesis-A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 Infection.

Authors:  Prapimpun Wongchitrat; Mayuri Shukla; Ramaswamy Sharma; Piyarat Govitrapong; Russel J Reiter
Journal:  Antioxidants (Basel)       Date:  2021-01-02

8.  Neuropathic Pain in Guillain-Barre Syndrome: Association with Rehabilitation Outcomes and Quality of Life.

Authors:  Tripti Swami; Meeka Khanna; Anupam Gupta; Navin B Prakash
Journal:  Ann Indian Acad Neurol       Date:  2020-11-07       Impact factor: 1.383

Review 9.  The effects of intravascular photobiomodulation on sleep disturbance caused by Guillain-Barré syndrome after Astrazeneca vaccine inoculation: Case report and literature review.

Authors:  Yuan-Ling Chang; Shin-Tsu Chang
Journal:  Medicine (Baltimore)       Date:  2022-02-11       Impact factor: 1.817

Review 10.  Neuropsychiatric manifestations in inflammatory neuropathies: A systematic review.

Authors:  Yusuf A Rajabally; Stefano Seri; Andrea E Cavanna
Journal:  Muscle Nerve       Date:  2016-05-10       Impact factor: 3.217

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.